Can I go to Hong Kong after IVF failure in Thailand? Doctor details referral conditions and process

Opening: Real consultation scenario

A patient who had two failed fresh embryo transfers in Thailand walked into the consultation room with a full set of examination reports, ovulation induction records, and embryo grading sheets, asking: "Doctor, can I continue? Would it be different in Hong Kong?" This is not an isolated case. In the past two years, the number of inquiries about transferring from Thailand to Hong Kong has increased, but whether a referral is reasonable and whether it can improve success rates needs to be broken down item by item.

1. Can I go to Hong Kong after IVF failure in Thailand?

Yes, but with two prerequisites: the cause of failure is basically clear, and Hong Kong's medical conditions can specifically address the existing problems. Simply changing locations without changing the strategy will not automatically improve the success rate.

When is a referral suitable:

• PGT screening has been performed in Thailand, with transferable euploid embryos, but repeated implantation failure requires investigation of uterine or immune factors
• Ovarian reserve is acceptable (AMH ≥ 1.2 ng/mL), but the response to the ovulation induction protocol in Thailand was poor, and you wish to try a different protocol in Hong Kong
• There are clear limitations of the laboratory conditions in Thailand (e.g., embryo culture technology, low blastocyst formation rate), and a Hong Kong laboratory may offer a more stable culture environment
• Specific genetic testing or gene diagnosis within the legal scope is needed, and Hong Kong's technology platform is a better match

When is immediate referral not suitable:

• The cause of failure is completely unknown, and you want to change locations without a systematic investigation
• Female age is over 42 and AMH is below 0.5 ng/mL, with very poor ovarian response to ovulation induction drugs; referral has limited value
• Untreated uterine issues exist (e.g., endometrial polyps, adhesions, chronic endometritis); these should be addressed before considering transfer
• Financial budget is tight; costs in Hong Kong are significantly higher than in Thailand, which may cause psychological stress and affect treatment

2. How do doctors view the referral?

IVF failure in Thailand generally falls into three categories:

• Embryo factors — Embryo chromosomal abnormalities, high fragmentation rate, poor developmental potential. These require PGT screening or adjusting the ovulation induction protocol to improve egg quality.
• Uterine factors — Poor endometrial receptivity, chronic endometritis, adhesions, or polyps. Hysteroscopy + endometrial microbiome/immunohistochemistry workup is needed.
• Maternal factors — Thyroid dysfunction, vitamin D deficiency, coagulation abnormalities, immune disorders. Consultation with relevant specialists is required.

Before a referral, I usually ask patients to complete three core assessments: hysteroscopy (to rule out endometrial pathology), endometrial biopsy + CD138 staining (to check for chronic endometritis), and peripheral blood immune and coagulation tests (antiphospholipid antibodies, NK cell activity, prothrombotic state, etc.). These may not have been fully done in some Thai facilities, but they are the first step in Hong Kong as well.

3. Thailand vs. Hong Kong: Differences in medical systems and technology

From a technical perspective, Hong Kong is generally more balanced in embryo culture stability, PGT detection accuracy, and laboratory quality control systems. However, some top-tier centers in Thailand (e.g., Jetanin, BNH) have laboratory standards comparable to Hong Kong, so it cannot be generalized.

4. Admission criteria and style differences among hospitals

Fertility centers in Hong Kong are mainly divided into public hospitals (e.g., Prince of Wales Hospital, Queen Mary Hospital) and private centers (e.g., Union Fertility Centre, Hong Kong Sanatorium & Hospital, Hong Kong Reproductive Medicine Centre).

• Public hospitals: Referral patients need a doctor's referral letter; waiting times are long, and there are strict restrictions on patient age and indications, generally prioritizing local residents. Cross-border patients usually take the private route.
• Private centers: They accept cross-border patients but require complete medical records, including ovulation induction protocols, embryo culture records, transfer records, and all examination reports. Some centers may require certain tests (e.g., hysteroscopy, endometrial biopsy) to be repeated to meet local medical standards.

When choosing a private center in Hong Kong, consider:

• Whether the laboratory has in-house PGT testing capability (or sends it to a third party)
• Whether they have experience in managing repeated implantation failure
• Whether they accept cross-border embryo transport (e.g., if you have frozen embryos in Thailand)

5. Details most easily overlooked

During the referral process, the following details are often overlooked but directly affect the smoothness of the procedure:

• Validity of examination reports: Hormone panel, AMH, infectious disease screening done in Thailand are usually accepted in Hong Kong if within 6 months. However, hysteroscopy, chromosome karyotyping, etc., are valid long-term. If reports expire, they need to be redone, adding time and cost.
• Embryo transport: If you have frozen embryos in Thailand, you need to confirm whether the Hong Kong center accepts external embryos and whether it complies with the legal requirements of both places. Embryo transport requires professional liquid nitrogen tanks and cold chain logistics, costing approximately RMB 10,000-30,000, and relevant procedures must be completed.
• Visa and stay duration: Hong Kong offers 7-14 day tourist visas for mainland residents, but a complete IVF cycle (ovulation induction + egg retrieval + transfer) requires at least 20-30 days. You need to plan visa arrangements in advance or travel in batches.
• Insurance coverage: Private hospitals in Hong Kong usually do not include medical insurance for cross-border patients. If complications such as Ovarian Hyperstimulation Syndrome occur during treatment, costs must be paid out-of-pocket. It is recommended to purchase travel insurance covering assisted reproduction complications.

6. Actual referral process

1. Collect complete medical records: Including all cycle records from Thailand (ovulation induction, egg retrieval, embryo culture reports including blastocyst grading and PGT reports, transfer records, endometrial preparation protocols, and all test reports (hormones, AMH, semen analysis, chromosomes, etc.).
2. Select a Hong Kong fertility center and submit a pre-assessment: Send the records to the target center for the medical team to evaluate whether to accept you and what additional tests are needed.
3. Complete supplementary tests: Based on the Hong Kong doctor's requirements, complete hysteroscopy, endometrial biopsy, immune-related tests, etc. Some tests can be done in a top-tier hospital in mainland China, but must be confirmed as acceptable by the Hong Kong doctor.
4. Initial consultation: Travel to Hong Kong for a face-to-face discussion with the doctor about the cause of failure analysis, new protocol design, medication plan, and cycle scheduling.
5. Develop a new protocol: Based on the assessment results, choose an ovulation induction protocol (e.g., switching from a long protocol to an antagonist protocol or PPOS protocol), or prepare directly for frozen embryo transfer.
6. Start the cycle: Begin ovulation induction or endometrial preparation according to the new protocol, and proceed with the transfer.

The entire process usually takes 1.5-3 months. If a new ovulation induction is not needed (frozen embryos available), the time can be shortened to about 1 month.

7. Timeline: How far in advance should you prepare?

From the decision to refer to formally starting the treatment cycle, it is recommended to allow the following time:

• Record organization and center communication: 2-4 weeks (including translation and supplementary tests)
• Supplementary tests and waiting for results: 2-4 weeks (hysteroscopy should be done 3-7 days after menstruation ends; endometrial biopsy during the mid-luteal phase)
• Initial consultation and protocol finalization: 1-2 days (requires one trip to Hong Kong)
• Starting the cycle (ovulation induction or frozen embryo transfer preparation): Depends on the menstrual cycle, usually 2-4 weeks

If you have frozen embryos in Thailand that need to be transported, add an additional 1-2 weeks for paperwork and logistics arrangements.

8. Factors affecting cost

The cost structure of IVF in Hong Kong is similar to Thailand, but overall 20%-40% higher. The main cost items are as follows:

• Initial consultation fee: HKD 800-2,000/session
• Ovulation induction medication: HKD 15,000-30,000 (depending on protocol and brand)
• Egg retrieval surgery fee: HKD 20,000-40,000 (including anesthesia)
• Embryo culture + transfer: HKD 30,000-50,000
• PGT testing: HKD 12,000-18,000 per embryo
• Frozen embryo transport: RMB 10,000-30,000 (if applicable)
• Hysteroscopy/endometrial biopsy: HKD 10,000-20,000

A complete autologous egg cycle (ovulation induction + egg retrieval + culture + transfer + PGT) in Hong Kong costs approximately HKD 150,000-220,000, equivalent to about RMB 130,000-190,000. If using frozen embryo transfer, the cost is about HKD 30,000-50,000.

9. Common questions and doctor's observations

Can I still transfer with low AMH?

AMH below 0.8 ng/mL indicates diminished ovarian reserve, but it is still worth trying. Hong Kong laboratories have some experience in culturing very few follicles, but the number of eggs retrieved usually does not exceed the AFC (antral follicle count). If the number of eggs retrieved in the Thai cycle was very low (fewer than 3), the potential for improvement after referral is limited. It is advisable to first assess whether continuing with autologous eggs is suitable.

What should I prepare for a referral at an advanced age (over 40)?

In addition to routine tests, it is recommended to add: Endometrial gene testing (ERA), immunohistochemistry, and comprehensive coagulation profile. Implantation failure in older patients is more often related to increased embryonic aneuploidy rates, making PGT a necessary option. Also, assess uterine artery blood flow and endometrial receptivity.

Will Hong Kong accept semen analysis done in Thailand?

Yes, but with a validity limit. Semen analysis (routine + morphology + DNA fragmentation) is valid for 6-12 months. If the report is over 1 year old, or if the testing method in the Thai lab is inconsistent with Hong Kong standards, the Hong Kong doctor may request a repeat. DNA fragmentation testing is valuable for repeated implantation failure, so it is recommended to have it rechecked in Hong Kong directly.

What documents do I need to prepare?

A valid Mainland Travel Permit for Hong Kong and Macao + a valid endorsement (individual tourist or medical endorsement). Some private centers require a notarized marriage certificate (if involving embryo freezing or PGT). Hong Kong does not require a fertility certificate or birth permit, but the hospital will have you sign an informed consent form.

10. Doctor's advice

Transferring to Hong Kong after IVF failure in Thailand is a feasible path, but not a shortcut. Before the referral, a systematic analysis of the cause of failure must be completed, and you must go with a clear problem to find the corresponding solution. If you simply feel vaguely that "changing places will bring better luck," it is recommended to complete a comprehensive investigation in mainland China or Thailand first before making a decision.

For younger patients (< 38 years old) with normal ovarian reserve and euploid embryos but repeated implantation failure, the value of transferring to Hong Kong is greatest — Hong Kong has a well-established system for endometrial receptivity assessment, immune infertility diagnosis, and laboratory quality control.

For older patients (> 42 years old) with significantly reduced ovarian function, or those who retrieved very few eggs in the Thai cycle, the benefits and costs should be fully evaluated before referral to avoid secondary harm from financial pressure and unmet psychological expectations.

Regardless of where you choose to be treated, the core of medical decision-making is always the cause, not the geographical location. Finding the reason for failure is more important than changing places.